Bortezomib

From Libre Pathology
Revision as of 13:14, 15 June 2016 by Jensflorian (talk | contribs) (Drug)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Bortezomib is a proteasome inhibitor to treat multiple myeloma and mantle cell lymphoma. The substance prevents degradation of pro-apoptotic factors, resulting activation of programmed cell death in neoplastic cells. [1]


References

  1. ↑ Curran, MP.; McKeage, K. (2009). "Bortezomib: a review of its use in patients with multiple myeloma.". Drugs 69 (7): 859-88. doi:10.2165/00003495-200969070-00006. PMID 19441872.
Retrieved from "https://librepathology.org/w/index.php?title=Bortezomib&oldid=44972"